WuXi AppTec Co., Ltd. (WUXIF)
USD 7.12
(0.0%)
USD 7.12
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 18.15 Billion CNY | 2.19% |
| 2022 | 17.76 Billion CNY | 8.51% |
| 2021 | 16.36 Billion CNY | 20.61% |
| 2020 | 13.57 Billion CNY | 14.74% |
| 2019 | 11.82 Billion CNY | 125.81% |
| 2018 | 5.23 Billion CNY | -10.33% |
| 2017 | 5.84 Billion CNY | 29.02% |
| 2016 | 4.52 Billion CNY | 39.06% |
| 2015 | 3.25 Billion CNY | 22.44% |
| 2014 | 2.65 Billion CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 18.89 Billion CNY | 4.07% |
| 2024 Q3 | 18.65 Billion CNY | -3.35% |
| 2024 Q2 | 19.3 Billion CNY | 2.18% |
| 2023 Q2 | 19.12 Billion CNY | 4.16% |
| 2023 Q1 | 18.35 Billion CNY | 3.34% |
| 2023 FY | 18.15 Billion CNY | 2.19% |
| 2023 Q4 | 18.15 Billion CNY | -8.19% |
| 2023 Q3 | 19.77 Billion CNY | 3.4% |
| 2022 Q3 | 20.61 Billion CNY | 5.59% |
| 2022 Q1 | 16.93 Billion CNY | 3.45% |
| 2022 FY | 17.76 Billion CNY | 8.51% |
| 2022 Q4 | 17.76 Billion CNY | -13.82% |
| 2022 Q2 | 19.52 Billion CNY | 15.26% |
| 2021 Q4 | 16.36 Billion CNY | 5.38% |
| 2021 FY | 16.36 Billion CNY | 20.61% |
| 2021 Q1 | 13.08 Billion CNY | -3.59% |
| 2021 Q2 | 15.19 Billion CNY | 16.12% |
| 2021 Q3 | 15.53 Billion CNY | 2.24% |
| 2020 Q4 | 13.57 Billion CNY | 9.19% |
| 2020 Q3 | 12.43 Billion CNY | 1.7% |
| 2020 Q2 | 12.22 Billion CNY | -1.28% |
| 2020 Q1 | 12.38 Billion CNY | 4.66% |
| 2020 FY | 13.57 Billion CNY | 14.74% |
| 2019 Q3 | 10.05 Billion CNY | 59.67% |
| 2019 FY | 11.82 Billion CNY | 125.81% |
| 2019 Q4 | 11.82 Billion CNY | 17.61% |
| 2019 Q2 | 6.29 Billion CNY | 29.19% |
| 2019 Q1 | 4.87 Billion CNY | -6.92% |
| 2018 Q4 | 5.23 Billion CNY | -14.54% |
| 2018 FY | 5.23 Billion CNY | -10.33% |
| 2018 Q3 | 6.13 Billion CNY | 5.58% |
| 2018 Q2 | 5.8 Billion CNY | 2.89% |
| 2018 Q1 | 5.64 Billion CNY | -3.41% |
| 2017 FY | 5.84 Billion CNY | 29.02% |
| 2017 Q3 | 5.38 Billion CNY | 0.0% |
| 2017 Q4 | 5.84 Billion CNY | 8.51% |
| 2017 Q1 | 3.95 Billion CNY | 0.0% |
| 2016 FY | 4.52 Billion CNY | 39.06% |
| 2015 FY | 3.25 Billion CNY | 22.44% |
| 2014 FY | 2.65 Billion CNY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| American Bio Medica Corporation | 3.6 Million USD | -503001.549% |
| Arrayit Corporation | 7.49 Million USD | -242035.379% |
| Atlantic International Corp. | 3.82 Million USD | -474011.126% |
| Biocept, Inc. | 22.01 Million USD | -82359.928% |
| Bioqual, Inc. | 18.93 Million USD | -95749.163% |
| CardioGenics Holdings Inc | 1.79 Million USD | -1011191.509% |
| DermTech, Inc. | 64.75 Million USD | -27931.664% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 734.97 Million USD | -2369.737% |
| HTG Molecular Diagnostics, Inc. | 12.38 Million USD | -146452.28% |
| iMD Companies, Inc. | 1.67 Million USD | -1084103.227% |
| IDenta Corp. | 1.01 Million USD | -1791516.302% |
| Interpace Biosciences, Inc. | 28.15 Million USD | -64366.754% |
| Integrative Health Technologies, Inc. | 297.94 Thousand USD | -6092226.452% |
| InVitro International | 78.99 Thousand USD | -22979902.398% |
| Lumos Diagnostics Holdings Limited | 19.72 Million USD | -91906.208% |
| Many Bright Ideas Technologies Inc. | 129.29 Thousand USD | -14038821.161% |
| Medical Imaging Corp. | 9.51 Million USD | -190629.64% |
| NovelStem International Corp. | 4.2 Million USD | -431463.551% |
| Optigenex Inc. | 9.57 Million USD | -189562.799% |
| PharmChem, Inc. | 558.64 Thousand USD | -3249161.858% |
| Proteome Sciences plc | 18.48 Million USD | -98076.499% |
| Response Genetics, Inc | 15.86 Million USD | -114300.352% |
| Rennova Health, Inc. | 49.66 Million USD | -36446.955% |
| RushNet, Inc. | 6.23 Million USD | -290842.894% |
| ScreenPro Security Inc. | 1.6 Million USD | -1133977.929% |
| Stella Diagnostics Inc. | 18 Million USD | -100713.638% |
| StageZero Life Sciences Ltd. | 8.2 Million USD | -221157.048% |
| Todos Medical Ltd. | 50.15 Million USD | -36090.171% |